search
  • Country
    Clear
  • Thematic
    Clear
  • Type
  • Compatibility Level
  • Jurisdiction
4,991 Data sources

  • GB
  • NL
  • SG
  • SE
  • EU
  • Thematic: No

  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • Record does not exist anymore: Environmental Information Data Centre . The record with identifier content 10.25504/FAIRsharing.9raft1 was invalid.Records previously linked: [3418, 3419, 3424, 3427, 3429, 3453]. Organisations previously linked: [2090, 461]. Licences previously linked: [115, 1056].

    more_vert
  • This repository provides access to a wide range of work produced by members of Nottingham Trent University, including journal articles, authored and edited books, book chapters, conference contributions and digital and visual media. A full description of all items is provided and, whenever possible, the full text (or equivalent).

    more_vert
  • chevron_left
  • 5
  • 6
  • 7
  • 8
  • 9
  • chevron_right
4,991 Data sources
  • more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • more_vert
  • more_vert
  • more_vert
  • Record does not exist anymore: Environmental Information Data Centre . The record with identifier content 10.25504/FAIRsharing.9raft1 was invalid.Records previously linked: [3418, 3419, 3424, 3427, 3429, 3453]. Organisations previously linked: [2090, 461]. Licences previously linked: [115, 1056].

    more_vert
  • This repository provides access to a wide range of work produced by members of Nottingham Trent University, including journal articles, authored and edited books, book chapters, conference contributions and digital and visual media. A full description of all items is provided and, whenever possible, the full text (or equivalent).

    more_vert
  • chevron_left
  • 5
  • 6
  • 7
  • 8
  • 9
  • chevron_right